Sustained Release Excipients Market Expansion Is Opening New Pathways For Strategic Investment
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Sustained Release Excipients Market Expansion Outlook: What Revenue Opportunities Lie Ahead?
The market for sustained release excipients has seen robust expansion over the past few years. Its value is projected to climb from $1.51 billion in 2025 to $1.63 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.2%. During the historic period, this growth has been driven by several factors, including rising rates of chronic diseases, a greater adoption of modified release tablets, progress in polymer chemistry, increased production of generic drugs, and wider regulatory acceptance of sustained release formulations.
The sustained release excipients market is projected to experience significant expansion over the coming years. By 2030, its value is anticipated to reach $2.3 billion, reflecting a compound annual growth rate (CAGR) of 8.9%. This upward trajectory during the forecast period is driven by several factors, including a heightened need for long-acting injectables, the expansion of biologics and specialty pharmaceuticals, increased funding for drug delivery research and development, a shift toward patient-focused formulations, and the growth of pharmaceutical production in emerging economies. Key developments shaping the market include a growing preference for controlled drug release systems, wider application of polymers in sustained release products, greater uptake of oral sustained release dosage forms, advancements in microencapsulation and coacervation techniques, and an emphasis on improving patient adherence while lowering dosing frequency.
Download A Free Sample Report For Comprehensive Market Insights:
Sustained Release Excipients Market Demand Drivers: What Is Fueling Industry Growth?
The increasing need for tailored therapeutic approaches is anticipated to boost expansion within the sustained-release excipients market in the coming period. This method, known as personalized medicine or individualized care, involves healthcare providers examining a patient’s distinct genetic makeup, proteins, and other biological characteristics to design and implement specifically customized treatment through precision-based techniques. Sustained-release excipients are integral to this field, as they facilitate the creation of drug delivery systems that are specifically adapted to the unique requirements of each person. For example, data from the Personalised Medicine Coalition, a healthcare organization located in the United States, indicates that in February 2024, the number of newly approved personalized treatments for rare diseases by the FDA reached 16 in 2023, a significant increase from the 6 recorded in 2022. Consequently, the rising demand for individualized medicine is fueling the onward development of the sustained-release excipients market.
Sustained Release Excipients Market Segment Analysis Highlighting Growth Areas
The sustained release excipients market covered in this report is segmented –
1) By Product: Gelatin, Polymers, Minerals, Chitosan
2) By Route of Administration: Oral, Intramuscular, Subcutaneous, Transdermal, Vaginal, Ophthalmic, Intravenous, Other Routes of Administration
3) By Technology: Targeted Delivery, Micro Encapsulation, Wurster Technique, Transdermal, Implants, Coacervation
Subsegments:
1) By Gelatin: Type A Gelatin, Type B Gelatin
2) By Polymers: Natural Polymers, Synthetic Polymers
3) By Minerals: Calcium Compounds, Magnesium Compounds, Other Mineral Excipients
4) By Chitosan: Low Molecular Weight Chitosan, High Molecular Weight Chitosan
Sustained Release Excipients Market Innovation Trends: Which Developments Are Transforming The Industry?
Leading players in the sustained release excipients sector are prioritizing the creation of sophisticated solutions, particularly multifunctional polymer platforms, aimed at improving drug formulation efficiency, shortening delivery timelines, and enabling controlled-release mechanisms. These platforms serve as excipients capable of facilitating immediate, delayed, and sustained drug release while maintaining compatibility with formulation techniques such as hot melt extrusion and solubility-enhancing spray drying. A case in point is September 2024, when Evonik—a Germany-based company—commenced operations at a new spray drying facility located at its Darmstadt site, dedicated to EUDRAGIT polymers. This facility boosts production capacity, cuts delivery durations, and is seamlessly incorporated into existing production networks. It relies on green electricity and steam sourced from local waste incineration, achieving an annual reduction in CO2 emissions exceeding 1,000 tons. Adhering to IPEC-GMP pharmaceutical guidelines and directly linked to the production of aqueous dispersions, the facility lessens transportation needs and optimizes supply chain flow. The polymers produced here enable immediate, delayed, and sustained release formulations, thereby bolstering Evonik’s status as a global center for oral drug delivery solutions and reinforcing its capacity to efficiently support innovative pharmaceutical development.
Sustained Release Excipients Market Leading Companies: Who Holds Significant Market Presence?
Major companies operating in the sustained release excipients market are BASF SE, Ashland Global Holdings Inc, Colorcon Inc, Evonik Industries AG, Lubrizol Corporation, Merck KGaA, Roquette Freres, Shin Etsu Chemical Co Ltd, JRS Pharma GmbH Co KG, SPI Pharma Inc, Croda International Plc, Lonza Group AG, Chemische Fabrik Budenheim KG, Asahi Kasei Corporation, DuPont de Nemours Inc, Dow Chemical Company, Eastman Chemical Company, Gattefosse SAS, Balchem Corporation, Associated British Foods plc, Ransom Naturals Ltd, Cellulose Solutions Private Limited
Access The Complete Sustained Release Excipients Market Report:
Sustained Release Excipients Market Geographic Analysis: Where Is Demand Growing The Fastest?
North America was the largest region in the global sustained release excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sustained release excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
